Ask Dr. Caplan AI
Inside the Clinical Intelligence Architecture
Why Ask Dr Caplan Delivers Unmatched Evidence Provenance
Navigating cannabinoid science requires distinguishing rigorous clinical trial data from widespread marketing claims. Ask Dr Caplan provides clinicians, researchers, and patients with instant access to an authoritative knowledge base rooted in peer-reviewed biomedical literature and decades of front-line clinical experience.
Real-world clinical observations providing deep insight into cannabinoid tolerance, efficacy, and side-effect management across diverse patient populations.
Systematic indexing of randomized controlled trials (RCTs), biochemical assays, receptor binding profiles, and pharmacokinetic analyses.
Continuous medical updates reflecting the latest discoveries in endocannabinoid system (ECS) pharmacology and targeted therapeutics.
Explore Cannabinoid Mechanisms, Dosing, and CYP450 Interactions
Cannabinoids interact with multiple physiological systems beyond classic CB1 and CB2 receptors, including TRPV1 vanilloid channels, 5-HT1A serotonin receptors, and PPAR-gamma nuclear receptors. Understanding these diverse pathways is essential for anticipating biphasic dose responses and identifying potential metabolic interactions involving the cytochrome P450 enzyme family (CYP3A4, CYP2C9, CYP2C19).
Frequently Asked Questions About Ask Dr Caplan
What is Ask Dr Caplan?
Ask Dr Caplan is a specialized clinical AI intelligence platform curated by board-certified physician Dr. Benjamin Caplan, MD. It synthesizes insights from over 400,000 patient encounters and 70,000 peer-reviewed scientific publications to deliver instant, evidence-grounded answers to medical cannabis questions.
Is Ask Dr Caplan providing direct medical prescriptions?
No. Ask Dr Caplan is an evidence-grounded scientific and educational tool designed to demystify cannabinoid pharmacology, clinical trial data, and therapeutic research. It is non-prescriptive and intended to inform discussions between patients and their licensed healthcare providers.
How does Ask Dr Caplan handle drug interactions and safety?
The platform cross-references known cytochrome P450 (CYP3A4, CYP2C9, CYP2C19) enzymatic pathways, evaluating pharmacokinetic interactions between major cannabinoids (such as THC, CBD, CBG, and CBN) and standard pharmaceutical medications like blood thinners, antiepileptics, and sedatives.
Where do the scientific citations come from?
Every clinical summary references peer-reviewed biomedical literature indexed on PubMed, NCBI, and international clinical trial registries, complete with direct DOI and PMID links for full verification.
How can healthcare providers use Ask Dr Caplan in clinical workflows?
Clinicians use the engine to quickly review biphasic dose-response curves, examine specific cannabinoid receptor affinities (CB1, CB2, TRPV1, 5-HT1A), and access recent human randomized controlled trial data to support evidence-based patient consultations.
How can I schedule a direct consultation with Dr. Benjamin Caplan?
Patients and healthcare professionals seeking individualized clinical evaluations can book directly through CED Clinic at cedclinic.com/book for comprehensive medical guidance.